| Bioactivity | HBPC-GSH is a glyoxalase (Glo) inhibitor (cGloI IC50=0.6 μM; cGloII IC50=1.6 μM), a glutathione derivative. HBPC-GSH can be used in antimalarial research[1]. |
| Name | HBPC–GSH |
| CAS | 1055039-06-9 |
| Formula | C17H23BrN4O8S |
| Molar Mass | 523.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Akoachere M, et al. Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts. Biol Chem. 2005 Jan;386(1):41-52. |
HBPC–GSH
CAS: 1055039-06-9 F: C17H23BrN4O8S W: 523.36
HBPC-GSH is a glyoxalase (Glo) inhibitor (cGloI IC50=0.6 μM; cGloII IC50=1.6 μM), a glutathione derivative. HBPC-GSH c
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.